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Abstract
Detection of viral nucleic acids plays a critical role in the induction of intracellular host
immune defences. However, the temporal recruitment of immune regulators to infecting
viral genomes remains poorly defined due to the technical difficulties associated with low
genome copy-number detection. Here we utilize 5-Ethynyl-2’-deoxyuridine (EdU) labelling
of herpes simplex virus 1 (HSV-1) DNA in combination with click chemistry to examine the
sequential recruitment of host immune regulators to infecting viral genomes under low multi-
plicity of infection conditions. Following viral genome entry into the nucleus, PML-nuclear
bodies (PML-NBs) rapidly entrapped viral DNA (vDNA) leading to a block in viral replication
in the absence of the viral PML-NB antagonist ICP0. This pre-existing intrinsic host defence
to infection occurred independently of the vDNA pathogen sensor IFI16 (Interferon Gamma
Inducible Protein 16) and the induction of interferon stimulated gene (ISG) expression, dem-
onstrating that vDNA entry into the nucleus alone is not sufficient to induce a robust innate
immune response. Saturation of this pre-existing intrinsic host defence during HSV-1 ICP0-
null mutant infection led to the stable recruitment of PML and IFI16 into vDNA complexes
associated with ICP4, and led to the induction of ISG expression. This induced innate
immune response occurred in a PML-, IFI16-, and Janus-Associated Kinase (JAK)-depen-
dent manner and was restricted by phosphonoacetic acid, demonstrating that vDNA poly-
merase activity is required for the robust induction of ISG expression during HSV-1
infection. Our data identifies dual roles for PML in the sequential regulation of intrinsic and
innate immunity to HSV-1 infection that are dependent on viral genome delivery to the
nucleus and the onset of vDNA replication, respectively. These intracellular host defences
are counteracted by ICP0, which targets PML for degradation from the outset of nuclear
infection to promote vDNA release from PML-NBs and the onset of HSV-1 lytic replication.
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Author summary
Intrinsic and innate immunity act to restrict the replication of many clinically important
viral pathogens. However, the temporal regulation of these two arms of host immunity
during virus infection remains poorly defined. A key aspect in the regulation of these
intracellular immune defences during herpesvirus infection is the rapid recruitment of
constitutively expressed immune regulators to infecting viral genomes. Here we show that
at physiologically low multiplicities of infection, PML-NBs rapidly entrap HSV-1 genomes
upon nuclear entry. Saturation of this pre-existing intrinsic host defence led to the stable
recruitment of the vDNA pathogen sensor IFI16 to HSV-1 vDNA and the induction of
ISG expression, an induced innate immune response dependent on the initiation of
vDNA replication. Importantly, both intrinsic and innate arms of host immunity required
PML, the principle scaffolding protein of PML-NBs. Our research identifies dual roles for
PML in the sequential regulation of intracellular host immunity during HSV-1 infection,
and highlights distinct phases in host immune factor recruitment to infecting viral
genomes required for the temporal regulation of intracellular host immune defences dur-
ing herpesvirus infection.
Introduction
Intrinsic, innate, and adaptive arms of host immunity cooperatively supress the replication
and spread of invading viral pathogens. Conferred by constitutively expressed host-cell restric-
tion factors, intrinsic immunity is the first line of intracellular defence against infection
(reviewed in [1–3]). In contrast, innate immune defences are upregulated following the activa-
tion of Pattern Recognition Receptors (PRRs) that detect Pathogen-Associated Molecular Pat-
terns (PAMPs) unique to microbial pathogens, including foreign viral nucleic acids. PRR
activation induces downstream signalling events that culminate in the expression of antiviral
host genes, principally cytokines (including interferons) and interferon stimulated gene (ISG)
products (reviewed in [4–6]). This induced innate immune response confers a broadly refrac-
tory antiviral state that limits virus propagation and stimulates adaptive immune responses.
Consequently, many viruses have evolved counter measures to antagonize intrinsic and innate
immune defences to promote their efficient propagation and transmission to new hosts.
A key event in the regulation of intracellular immune defences during herpesvirus infection
is the rapid recruitment of constitutively expressed host factors to sites in close proximity to
infecting viral genomes upon nuclear entry (reviewed in [1, 7]). These factors include core
constituent proteins of Promyelocytic Leukaemia Nuclear Bodies (PML-NBs; notably PML,
Sp100, Daxx and ATRX; [8–10]), innate immune regulators (IFI16, cGAS, and STING; [11–
14]), DNA Damage Response (DDR) proteins (γH2AX, Mdc1, 53BP1, and BRCA1; [15]), and
core component proteins of the SUMOylation pathway (SUMO-1, SUMO-2/3, PIAS1, and
PIAS4 [16–19]). The recruitment of these host factors represents the earliest detectable nuclear
responses to infection, and have been linked to the repression of viral gene expression and
PRR activation in the regulation of intrinsic and innate immune defences, respectively. The
importance of PML-NB constituent proteins and IFI16 in the regulation of intracellular
immunity is highlighted by the fact that many viruses have evolved strategies to antagonise
these key immune regulators (reviewed in [1, 4, 6, 20, 21]). One of the first viral proteins to be
expressed during Herpes Simplex Virus 1 (HSV-1) infection is ICP0, a viral RING-finger ubi-
quitin ligase that promotes the degradation and dispersal of host factors, including PML and
IFI16 [11, 22–31], away from infecting viral genomes (reviewed in [7, 32]). This activity
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inhibits viral genome silencing and the induction of ISG expression, thereby promoting the
efficient onset of HSV-1 gene expression and replication. Viral mutants that do not express
ICP0, or carry mutations that impair its ubiquitin ligase activity, are highly susceptible to host-
cell restriction at low multiplicities of infection (MOI) and are hypersensitive to interferon
(IFN) treatment [33–38]. The use of such mutants has been critical in defining many aspects
relating to the regulation of intrinsic and innate immunity during herpesvirus infection. Stud-
ies analysing the recruitment of host immune regulators to infecting viral genomes have typi-
cally relied on high MOI conditions due to the technical challenges associated with low
genome copy-number detection. A defining hallmark of intrinsic immunity, however, is that
this host defence is readily saturated under high MOI conditions due to limiting levels of pre-
existing host factors. Thus, much of the mechanistic detail of immune regulator recruitment to
infecting HSV-1 genomes has been established using viral mutants at input genome levels that
saturate intrinsic host defences. Consequently, the temporal recruitment of intrinsic and
innate immune regulators to infecting viral genomes remains poorly defined, specifically
under low MOI conditions pertinent to wild-type (WT) herpesvirus infections observed in a
clinical setting.
Here we use fluorophore conjugation by click chemistry to investigate the temporal recruit-
ment of intrinsic and innate immune regulators to 5-Ethynyl-2’-deoxyuridine (EdU) labelled
HSV-1 genomes under physiologically low MOI conditions (0.1 to 3 PFU/cell). HSV-1
genomes were readily detected in the nucleus within 30 minutes of infection (post-addition of
virus) and to be stably entrapped within PML-NBs in restrictive cell types prior to PML-NB
disruption and genome release by ICP0. PML-NB entrapment of vDNA occurred indepen-
dently of the PRR sensor IFI16 and ISG expression, demonstrating that this intrinsic host
response does not directly contribute to the induction of innate immunity. Saturation of this
host defence during HSV-1 ICP0-null mutant infection led to the stable recruitment of PML
and IFI16 into vDNA complexes associated with ICP4, and the subsequent induction of ISGs.
This induced innate immune response occurred in a PML-, IFI16-, and Janus associated kinase
(JAK) dependent manner, which could be suppressed by the vDNA polymerase inhibitor
phosphonoacetic acid (PAA). These data demonstrate that vDNA entry into the nucleus alone
under low MOI conditions is not sufficient to stimulate a robust innate immune response to
HSV-1 nuclear infection, which only occurs after the onset of vDNA replication. We show that
intrinsic and innate arms of intracellular host immunity act sequentially, as inhibition of
innate immune signalling could not relieve the intrinsic cellular restriction of an HSV-1
ICP0-null mutant, but instead led to significantly enhanced virus yields under infection condi-
tions that enabled the onset of vDNA replication. Collectively, our data demonstrate that
intrinsic and innate arms of host immunity are temporally distinct immune events activated in
response to vDNA nuclear entry and the onset of vDNA replication, respectively. Our data
identifies distinct roles for PML in the sequential regulation of these intracellular immune
defences to HSV-1 infection, findings that are likely to be highly pertinent in the cellular
restriction of many nuclear replicating viral pathogens.
Results
Direct visualization of bio-orthogonally labelled input HSV-1 genomes at
low MOI
Microscopy studies have played pivotal roles in the identification of host factors and signalling
pathways that contribute to the intracellular regulation of intrinsic and innate immunity dur-
ing herpesvirus infection (reviewed in [1, 4, 7, 32, 39]). However, the detection of viral
genomes under low MOI conditions, which do not saturate intrinsic host defences, remains a
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significant technical challenge. To date, viral genome localization studies have relied on the
indirect detection of vDNA through immunolabelling or fluorescent tagging of vDNA binding
proteins, for example the viral immediate early (IE) transcription factor ICP4 or the early (E)
single-stranded vDNA binding protein ICP8 [8–10, 13, 14, 40]. The use of vDNA binding pro-
teins limits temporal resolution of host factor recruitment to infecting viral genomes, as
genome detection requires the successful expression of viral gene products that may compete
with, or displace, host factors bound to vDNA. Consequently, this strategy is suboptimal for
the examination of early intrinsic host immune defences that influence the cellular restriction
of viral gene expression. While direct vDNA labelling strategies have been employed, most
notably fluorescent in situ hybridization (FISH; [8, 10]), such approaches require harsh dena-
turing conditions which impair host antigen detection ([41], personal communication J.
Brown), and have not been widely adopted. Recent advances in direct bio-orthogonal nucleic
acid labelling, using Ethynyl-tagged deoxynucleotides in combination with fluorescent label-
ling by click chemistry techniques, have enabled the direct visualization of vDNA during both
Adeno- and Herpesvirus infection ([42–46]). We sought to apply this technique by purifying
either EdU or EdC labelled HSV-1 virions (HSV-1EdU or HSV-1EdC, respectively) and infect-
ing cells at low MOI ( 3 PFU/cell) to examine the temporal recruitment of intrinsic and
innate immune regulators to input viral genomes following nuclear entry.
Successful labelling of vDNA and the purification of high titre WT or ICP0-null mutant
HSV-1EdU or HSV-1EdC stocks was achieved by infecting Retinal Pigmented Epithelial (RPE)
cells (see Materials and methods; S1A–S1C Fig). Notably, many laboratory cell lines were
unable to support efficient viral propagation at nucleotide concentrations exceeding 1 μM in
an Ethynyl-tag dependent manner (S1 Table, S1D–S1F Fig). As RPE cells were restrictive to
HSV-1 ICP0-null mutant replication (see below) and sensitive to Ethynyl-tagged deoxynucleo-
tide labelling in the absence of ICP0 (S1G–S1I Fig), we selected the lowest dose of 0.5 μM EdU
or EdC for genome labelling to enable comparative recruitment studies to input viral genomes
in the presence or absence of ICP0. In vitro genome release assays demonstrated that 60% of
virions contained EdU or EdC labelled viral genomes detectable by click chemistry following
partial denaturation of the HSV-1 capsid by 2M guanidine hydrochloride (GuHCl, Fig 1A–1C,
S2 Fig; [47]). Particle to plaque forming unit (PFU) analysis of virus preparations grown in the
presence of EdU demonstrated that HSV-1EdU labelled virions had a roughly equivalent ratio
to that of unlabelled control virus preparations (within 3-fold; S2 Table). These data demon-
strate that EdU labelling of vDNA was not significantly detrimental to virion production or
infectivity under these labelling conditions.
A time course of infection of human foreskin fibroblast (HFt) cells with WT (HSV-1EdU) or
ICP0-null (ΔICP0EdU) mutant HSV-1 demonstrated that vDNA could be readily detected
within the nuclei of infected cells as early as 30 minutes post-infection (mpi; post-addition of
virus), with> 70% of nuclei containing at least 1 (median average of 2) HSV-1EdU genome
foci by 120 mpi (Fig 1D, 1F and 1G). Signal detection was dependent on both HSV-1 infection
and EdU vDNA labelling, demonstrating that fluorescent click signal(s) were specific to input
EdU labelled vDNA (Fig 1E), with the majority of genome signals ( 70%) observed within
the nucleus (Fig 1H). Notably, qPCR analysis (S2 Table) revealed that the majority of particles
(> 50%) had yet to release their genomes by 120 mpi (post-addition of virus). As vDNA is
undetectable within native capsids (S2 Fig), these data suggest that the process of nuclear infec-
tion is still ongoing at 120 mpi. We note that under equivalent MOI conditions, ΔICP0EdU
infected cells had a reduced number of vDNA positive nuclei at each time point (Fig 1F–1H), a
phenotype that likely reflects the efficiency of ICP0-null mutant EdU vDNA labelling in
restrictive RPE cells (S1G–S1I Fig).
Temporal regulation of intracellular immunity to HSV-1 infection
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PML-NBs entrap WT HSV-1 genomes upon nuclear entry
With the ability to detect input vDNA within the nuclei of infected cells as early as 30 mpi
(post-addition of virus), we next assessed the utility of this approach to investigate the recruit-
ment of intrinsic immune factors to infecting WT HSV-1EdU genomes over a short time-
course of infection (30 to 90 mpi; Fig 2). Using a combination of click chemistry to detect
vDNA and immuno-labelling to detect PML-NB intrinsic host factors, PML (the main scaf-
folding protein of PML-NBs; [48]) and Daxx (a core constituent protein of PML-NBs; [48])
were observed to stably colocalize with vDNA over the time course of infection (30–90 mpi;
Fig 1. Direct visualization of bio-orthogonally labelled HSV-1 genomes. Quantitation of bio-orthogonally labelled vDNA in HSV-1 virions. HSV-1EdU
or HSV-1EdC virions were subjected to partial denaturation with 2M GuHCl at 4˚C for 60 mins to release vDNA [47]. vDNA (red) was detected by click
chemistry and capsid (green) by indirect immunofluorescence staining. (A) Representative confocal images showing vDNA release and expansion from
partially denatured HSV-1EdU virions following GuHCl treatment. (B,C) Stack plots showing the relative population of EdU or EdC positive vDNA
labelled HSV-1 virions. n 3000 particles per population derived from 3 independent experiments. Minimum estimates for viral genome labelling
efficiency are shown (%). (D,E) HFt cells were mock or HSV-1 infected with either unlabelled or EdU labelled WT (HSV-1EdU) or ICP0-null mutant HSV-
1 (ΔICP0EdU) at an MOI of 3 PFU/cell. Cells were fixed and permeabilized at the indicated times minutes post-infection (mpi; post-addition of virus).
vDNA was detected by click chemistry (white arrows) and nuclei stained with DAPI (blue). Representative confocal images showing the nuclear
accumulation of HSV-1EdU and ΔICP0EdU genomes over time (30–120 mpi; as indicated), with genome detection specific to input EdU labelled virus. (F)
Quantitation of HSV-1EdU or ΔICP0EdU genome positive nuclei over time (as in D). Boxes: 25th to 75th percentile range; black line: median; whiskers: 5th to
95th percentile range. n 300 cells per sample population derived from a minimum of 3 independent experiments. (G) Number of genomes detected
within infected nuclei at 120 mpi. Boxes: 25th to 75th percentile range; black line: median; whiskers: minimum and maximum range of sample. n 200
cells per sample population derived from a minimum of 3 independent experiments. (H) Nuclear (Nuc.) and cytoplasmic (Cyto.) distribution of genome
foci detected at 120 mpi. n 300 cells per sample population derived from a minimum of 3 independent experiments. Percentage of total genomes
detected within the nucleus is shown (%).
https://doi.org/10.1371/journal.ppat.1006769.g001
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Fig 2. PML-NBs stably entrap vDNA upon nuclear entry. HFt cells were mock or HSV-1EdU infected at an MOI of 3 PFU/cell. Cells were fixed and
permeabilized at the indicated times (mpi; post-addition of virus). vDNA, or PML-NB host factors and ICP0, were detected by click chemistry and indirect
immunofluorescence staining, respectively. (A) Localization of PML (green) and Daxx (cyan) to HSV-1 vDNA (red, white arrows) at 30–90 mpi (as
indicated). Insets show magnified regions of interest (dashed boxes) highlighting PML-NB colocalization with vDNA. Cut mask (yellow) highlights regions
of colocalization between PML, Daxx, and vDNA (as indicated). Weighted colocalization coefficients are shown. (B) 3D reconstruction of high-resolution
confocal Z-series images showing PML (green) entrapment of vDNA (red, white arrow) at 90 mpi. Single channel maximum intensity projections (left-
Temporal regulation of intracellular immunity to HSV-1 infection
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Fig 2A). High-resolution Z-series imaging revealed input vDNA to be encased in PML follow-
ing nuclear infection (Fig 2B). At 90 mpi, ICP0 could be observed to colocalize with PML-NBs
prior to PML degradation and PML-NB disruption (Fig 2C and 2D; [22, 25–27]). ICP0 locali-
zation at multiple PML-NBs demonstrates that vDNA entrapment within any single PML-NB
is not sufficient to target ICP0 to that specific body (Fig 2C). Western blotting of infected cell
lysates demonstrated that EdU labelling of vDNA was not detrimental to the initiation of IE
gene expression (ICP0, ICP4) or the degradation of PML (Fig 2D). Collectively, these data that
demonstrate infecting WT HSV-1 genomes are rapidly encased by PML-NB intrinsic host fac-
tors from the outset of nuclear infection prior to the onset of lytic replication. Our data con-
trast with previous recruitment studies, which have reported PML-NB constituent proteins to
localize to sites in close proximity to infecting viral genomes [8–10, 40]. However, we note that
these studies have typically relied on higher MOI conditions ( 10 PFU/cell; [10]), the use of
vDNA binding proteins to enable genome detection by proxy, or time points post-infection
where vDNA replication proteins are readily detectable. We conclude that PML-NB host fac-
tors rapidly entrap viral genomes shortly after nuclear entry prior to the robust onset of viral
gene expression (Fig 2D).
Asynchronous plaque-edge recruitment studies have shown that PML-NB host factors are
independently recruited to infecting viral genomes [49, 50] in an IFI16-dependent manner
[11, 12, 14], where de novo PML-NB like foci are reformed [10]. We therefore assessed the
composition of vDNA containing PML-NBs, as well as the localization of the PRR IFI16, to
infecting WT HSV-1EdU or HSV-1EdC genomes (Fig 3, S3 Fig). High colocalization frequencies
(weighted colocalization coefficients > 0.7) were observed for all PML-NB component pro-
teins examined (PML, Daxx, Sp100, ATRX, and SUMO2/3) to infecting viral genomes irre-
spective of genome label, with equivalent paired colocalization frequencies observed for
resident PML-NB proteins in mock-infected cells (Fig 3A–3D and 3F, S3 Fig). These data dem-
onstrate that PML-NBs that contained vDNA were indistinguishable in composition from
other PML-NBs within the same infected cell or in mock-infected cells at 90 mpi. Surprisingly,
the colocalization frequency between IFI16 and input viral genomes was below coincident
threshold levels (weighted colocalization coefficients < 0.2; solid line), demonstrating that
IFI16 does not stably localize with viral genomes entrapped within PML-NBs at 90 mpi (Fig
3E and 3F, S3 Fig). These data again contrast with published asynchronous plaque-edge
recruitment studies that have used vDNA binding proteins for genome detection, which have
shown IFI16 and PML to both localize to infecting HSV-1 ICP0-null mutant genomes [11, 13,
14]. As ICP0 has been reported to promote the degradation of IFI16 [11, 28–31], we examined
the recruitment of IFI16 to ΔICP0EdU genomes to investigate the potential effect of ICP0
expression on IFI16 localization to vDNA. No stable localization of IFI16 could be observed to
infecting ΔICP0EdU genomes (S4 Fig), demonstrating that a lack of stable IFI16 recruitment to
viral genomes was not due to low levels of ICP0 expression at 90 mpi (Fig 2C). We note that
IFI16 localization to viral genomes has been reported to be highly dynamic [12, 14], which
could potentially be inhibited by PML-NB entrapment of vDNA. We therefore investigated
the influence of MOI (1, 10, and 50 PFU/cell) and time (15 or 30 mpi) on the recruitment of
hand panels) and 3D rendered image (right-hand panel). Pearson coefficient for PML-vDNA colocalization is shown. Scale bar 2 μm. (C) Nuclear
localization of ICP0 (green) to vDNA (red, white arrow) and PML (cyan) in HSV-1EdU infected cells at 90 mpi. Cut mask (yellow) highlights regions of
colocalization between ICP0, PML, and vDNA (as indicated). Weighted colocalization coefficients are shown. Nuclei stained with DAPI (blue). (D) EdU
labelling of viral genomes does not affect the initiation of infection. HFt cells were mock or HSV-1 infected with unlabelled (HSV-1) or EdU labelled (HSV-
1EdU) HSV-1 at an MOI of 3 PFU/cell. Whole cell lysates were collected at the indicated times (hours post-infection; hpi) for western blot analysis to
monitor the rate of PML degradation and the accumulation of the viral immediate early (IE) gene products (ICP0, ICP4). Actin is shown as a loading
control. Molecular mass markers are shown,< denotes the detection of a non-specific background band.
https://doi.org/10.1371/journal.ppat.1006769.g002
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IFI16 and PML to nuclear infecting HSV-1EdU genomes (S5 Fig). While vDNA-IFI16 colocali-
zation could be observed under very high MOI conditions (50 PFU/cell; S5A Fig), quantitation
(n 250 genomes) revealed the frequency of these colocalization events was not significantly
altered by MOI or time (S5B–S5E Fig). In contrast, PML colocalization with vDNA was
Fig 3. Core PML-NB proteins, but not IFI16, associate with infecting HSV-1 genomes. HFt cells were mock or infected with either HSV-1EdU or HSV-
1EdC at an MOI of 3 PFU/cell. Cells were fixed and permeabilized at the indicated times (mpi; post-addition of virus). vDNA and PML-NB host factors were
detected by click chemistry and indirect immunofluorescence staining, respectively. (A-E) Localization of PML (green), and either Daxx, Sp100, ATRX,
SUMO2/3 (SUMO), or IFI16 (cyan; as indicated) to infecting HSV-1EdU vDNA (red, white arrows). Insets show magnified regions of interest (dashed
boxes) highlighting host protein localization with vDNA. Cut mask (yellow) highlights regions of colocalization between host proteins and vDNA (as
indicated). Weighted colocalization coefficients are shown. Individual channel images shown in S3 Fig. Nuclei were stained with DAPI (blue). (F)
Quantitation of host protein recruitment to infecting viral genomes labelled with EdU (as shown in A-E) or EdC. Boxes: 25th to 75th percentile range; black
line: median weighted (w.) colocalization coefficient; whiskers: 5th to 95th percentile range. Solid line indicates coincident threshold level (weighted
colocalization coefficients< 0.2). n 50 vDNA foci per sample population from a minimum of three independent infections.
https://doi.org/10.1371/journal.ppat.1006769.g003
Temporal regulation of intracellular immunity to HSV-1 infection
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006769 January 8, 2018 8 / 36
significantly reduced in a MOI dependent manner (1–50 PFU/cell), indicative of PML-NB sat-
uration by viral genomes or disruption by ICP0 under these high MOI conditions. PML
recruitment to vDNA also occurred in a time dependent manner, with a significant increase in
colocalization frequency between 15 and 30 mpi (MOI of 10 PFU/cell). As bio-orthogonal
nucleic acid labelling is incompatible with live-cell kinetic studies, we conclude that IFI16 does
not form a stable association with input vDNA following genome entry into the nucleus.
IFI16 recruitment to input viral genomes is not enhanced in the absence of
PML
To test if PML-NBs competitively exclude IFI16 from binding vDNA following nuclear entry,
we investigated the recruitment of IFI16 and Daxx (as a positive control; [49]) to input HSV-
1EdU and ΔICP0EdU genomes in cells depleted of PML (Fig 4, S6 Fig). HFt cells were stably
transduced with lentiviral vectors expressing non-targeting control or PML-targeting short
hairpin RNAs (shCtrl and shPML, respectively; [49]). qRT-PCR and western blotting con-
firmed PML depletion without influencing Daxx or IFI16 expression (Fig 4A and 4B). HSV-
1EdU or ΔICP0EdU infection of shCtrl cells recapitulated observations made in parental HFt
cells (Fig 3, S3 Fig, S4 Fig), demonstrating that lentiviral transduction, shRNA expression, or
puromycin selection did not affect PML-NB entrapment of vDNA or alter IFI16 localization
(Fig 4C–4E). PML depletion did not increase the frequency of IFI16 colocalization with vDNA
during either HSV-1EdU or ΔICP0EdU infection (Fig 4D and 4E, S6 Fig), demonstrating that
PML-NBs do not competitively exclude IFI16 from binding vDNA. In contrast, while Daxx
colocalized with vDNA in a subset of PML depleted cells (Fig 4C, S6A Fig), quantitation
(n 100 genomes) revealed that the frequency of this colocalization was significantly reduced
compared to control cells irrespective of ICP0 expression (Fig 4E). These data contrast with
asynchronous plaque-edge recruitment studies, where Daxx recruitment to infecting viral
genomes occurs in a PML independent manner under high MOI conditions [49]. We con-
clude that under infection conditions that do not saturate or disrupt PML-NBs by 90 mpi
(MOI < 10 PFU/cell; S5 Fig), Daxx colocalization with vDNA is stabilized by PML at
PML-NBs where Daxx is a resident protein (Figs 2–4, S3 Fig; [48]).
Live cell microscopy studies and asynchronous plaque-edge recruitment assays have
reported that IFI16 is required for PML and Daxx recruitment to infecting viral genomes [11,
12, 14], although no direct evidence of IFI16 colocalization with vDNA or deposition within
PML-NBs was reported to support this hypothesis. We therefore investigated if IFI16 played a
role in PML-NB entrapment of vDNA (Fig 5). HFt cells were stably transduced with lentiviral
vectors expressing non-targeting control or IFI16-targeting short hairpin RNAs (shCtrl and
shIFI16, respectively; [11]). qRT-PCR and western blotting confirmed IFI16 depletion without
influencing PML or Daxx expression (Fig 5A and 5B). HSV-1EdU infection of shCtrl or
shIFI16 cells demonstrated that both PML and Daxx strongly colocalized with vDNA indepen-
dently of IFI16 (Fig 5C–5E). We conclude that IFI16 does not play an essential role in the
entrapment of vDNA within PML-NBs. As we failed to observe any significant recruitment of
IFI16 to infecting HSV-1 genomes under a range of infection conditions, our data suggest that
the stable recruitment of PML and IFI16 to infecting viral genomes occurs with temporally dis-
tinct kinetics.
vDNA entry into the nucleus is not sufficient to induce ISG expression
As asynchronous plaque-edge recruitment assays have played a key role in defining the
recruitment of IFI16 to infecting HSV-1 genomes [11, 13, 14], we conducted analogous assays
to assess the temporal recruitment of PML and IFI16 to both vDNA and ICP4, an IE vDNA
Temporal regulation of intracellular immunity to HSV-1 infection
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Fig 4. Depletion of PML does not enhance the recruitment of IFI16 to infecting viral genomes. HFt cells were stably transduced with lentiviruses
expressing PML-targeting (shPML) or non-targeting control (shCtrl) shRNAs. (A) qRT-PCR quantitation of PML or IFI16 mRNA levels in HFt shCtrl and
shPML cells. Mean (RQ) and standard deviation (RQmin/max) shown and expressed relative to HFt shCtrl cells (1). (B) Western blot analysis of the
expression levels of PML, Daxx and IFI16 in whole cell lysates derived from HFt shCtrl and shPML cells. Actin is shown as a loading control. Molecular
mass markers are shown. (C, D) Localization of PML (green), and either Daxx or IFI16 (cyan; as indicated), to infecting HSV-1EdU vDNA (red, white
arrows) in HFt shCtrl and shPML cells at 90 mpi (post-addition of virus). Cells were infected with HSV-1EdU or ΔICP0EdU at an MOI of 3 PFU/cell. Insets
show magnified regions of interest (dashed boxes) highlighting host protein localization with vDNA. Cut mask (yellow) highlights regions of colocalization
between PML, IFI16, Daxx, and vDNA (as indicated). Weighted colocalization coefficients are shown. Nuclei were stained with DAPI (blue). Images for
ΔICP0EdU infected cells are shown in S6 Fig. (E) Quantitation of host protein recruitment to infecting viral genomes (as shown in C, D, S6). Boxes: 25th to
75th percentile range; black line: median weighted (w.) colocalization coefficient; whiskers: 5th to 95th percentile range. Solid line indicates coincident
threshold level (weighted colocalization coefficients< 0.2). n 50 vDNA foci per sample population from a minimum of four independent infections. 
P< 0.001, Mann-Whitney U-test.
https://doi.org/10.1371/journal.ppat.1006769.g004
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binding protein commonly utilized as a proxy for vDNA in genome recruitment studies [9–11,
14, 40]. Viral DNA labelling was achieved by pulse labelling HSV-1 ICP0-null mutant infected
Fig 5. IFI16 does not influence the recruitment of PML or Daxx to infecting viral genomes. HFt cells were stably transduced with lentiviruses expressing
IFI16-targeting (shIFI16) or non-targeting control (shCtrl) shRNAs. (A) qRT-PCR quantitation of IFI16 or PML mRNA levels in HFt shCtrl and shIFI16
cells. Mean (RQ) and standard deviation (RQmin/max) shown and expressed relative to HFt shCtrl cells (1). (B) Western blot analysis of the expression
levels of IFI16, PML, and Daxx in whole cell lysates from HFt shCtrl and shIFI16 cells. Actin is shown as a loading control. Molecular mass markers are
shown. (C, D) Localization of PML (green), and either IFI16 or Daxx (cyan; as indicated) to infecting HSV-1EdU vDNA (red, white arrows) in HFt shCtrl
and shIFI16 cells at 90 mpi (post-addition of virus). Cells were infected with HSV-1EdU at an MOI of 3 PFU/cell. Insets show magnified regions of interest
(dashed boxes) highlighting host protein localization with vDNA. Cut mask (yellow) highlights regions of colocalization between IFI16, PML, Daxx, and
vDNA (as indicated). Weighted colocalization coefficients are shown. Nuclei were stained with DAPI (blue). (E) Quantitation of host protein recruitment
to infecting viral genomes (as shown in C, D). Boxes: 25th to 75th percentile range; black line: median weighted (w.) colocalization coefficient; whiskers: 5th
to 95th percentile range. Solid line indicates coincident threshold level (weighted colocalization coefficients< 0.2). n 50 vDNA foci per sample
population from a minimum of four independent infections. ns (not significant), Mann-Whitney U-test.
https://doi.org/10.1371/journal.ppat.1006769.g005
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cell monolayers at 24 hours post-infection (hpi) with 1 μM EdU for 6 h. Under these condi-
tions, DNA replication compartments within the body of a developing plaque were clearly
detected (S7 Fig). Cells on the periphery of the plaque-edge were readily observed to contain
EdU positive vDNA foci asymmetrically distributed around the nuclear rim prior to ICP4
detection (Figs 6A, 6C top panels, S7), indicative of input EdU labelled viral genomes that have
yet to initiate a productive gene expression programme. The recruitment of PML to infecting
viral genomes occurred independently of ICP4 expression, with many genome foci observed
to localise in close proximity to PML foci (Fig 6A and 6B). In contrast, IFI16 recruitment only
occurred in cells that expressed ICP4 localized to vDNA at the nuclear rim (ICP4 NR; Fig 6C
and 6D, S7 Fig). These data support previous asynchronous recruitment studies that have used
ICP4 as a proxy for genome detection [11, 14] and demonstrate that PML and IFI16 are
recruited to infecting viral genomes with temporally distinct kinetics, which in the case of
IFI16 correlates with the expression and localization of viral gene products with vDNA (Fig
6D). Importantly, these data suggest that vDNA entry into the nucleus alone may not be suffi-
cient to stimulate the induction of an IFI16-dependent innate immune response, but instead
require the expression of specific viral gene products or the initiation of vDNA replication.
To test this hypothesis, we examined the induction of Mx1, a well-characterized ISG prod-
uct [51], during HSV-1 ICP0-null mutant infection by confocal microscopy. HFt cells were
mock treated, stimulated with IFN-β (as a positive control), or infected with ΔICP0EdU at
input levels which either restrict or permit the initiation of HSV-1 ICP0-null mutant replica-
tion and plaque formation at 24 hpi (MOI 0.1 and 1.0 PFU/cell, respectively; Fig 6E). vDNA
was readily detectible within the nuclei of infected cells under restrictive MOI conditions (0.1
PFU/cell) with a frequency close its expected input genome ratio (Fig 6F) and copy number
(1–2 genomes/infected cell; Fig 6G, S2 Table). Notably, the number of genomes per infected
cell nuclei under permissive conditions (MOI 1 PFU/cell) was lower than expected based on
our input qPCR analysis (~ 25 genomes/cell; Fig 6G, S2 Table). These data indicate that under
MOI conditions that begin to saturate intrinsic host defences (~ 10–20 genome copies/nuclei),
ΔICP0EdU genome detection is lost following the onset of vDNA replication by 24 hpi.
As expected, IFN-β stimulation efficiently induced Mx1 expression 24 h post-treatment
(Fig 6H and 6I). In contrast, infection with ICP0-null mutant HSV-1 only stimulated Mx1
expression at genome input levels sufficient to stimulate the onset of viral replication and pla-
que formation (MOI 1.0 PFU/cell; Fig 6E, 6H and 6I). High-resolution Z-series imaging
revealed that viral genomes remained stably entrapped within PML-NBs under restrictive
MOI conditions (0.1 PFU/cell) at 24 hpi (Fig 6J). These data demonstrate that under infection
conditions that restrict the initiation of ICP0-null mutant HSV-1 replication, viral genome
entry into the nucleus alone is not sufficient to stimulate the induction Mx1 ISG expression.
vDNA replication is required for the induction of innate immunity
As PML-NB entrapped HSV-1 ICP0-null mutant genomes failed to stimulate the induction of
Mx1 expression, we next examined the kinetics of ISG induction during HSV-1 infection
under MOI conditions that enabled the onset of viral replication (MOI 1 PFU/cell; Fig 7). As
expected, HSV-1 ICP0-null mutant infection efficiently induced the transcription (by 8–9 hpi)
and expression (by 16 hpi) of three independent ISG products (Mx1, ISG15, and ISG54), a host
response that was significantly impaired during WT HSV-1 infection (Fig 7A–7C). Impor-
tantly, the induction of ISGs only occurred under infection conditions that enabled the onset
of ICP0-null mutant HSV-1 replication and plaque-formation ( 1.0 PFU/cell; Figs 6E and
7D). Consistent with our microscopy observations (Fig 6H and 6I), these data demonstrate
that saturation of intrinsic host defences is required for the robust induction of ISGs during
Temporal regulation of intracellular immunity to HSV-1 infection
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006769 January 8, 2018 12 / 36
Fig 6. Nuclear entry of vDNA is not sufficient to induce robust Mx1 ISG expression. (A-D) Recruitment of PML, IFI16, and eYFP.ICP4 to ΔICP0
infecting viral genomes in an asynchronous plaque-edge recruitment assay (as described in [10]). HFt cells were infected with ΔICP0 expressing eYFP.ICP4
under conditions (MOI 2 PFU/cell) that enable plaque-formation to occur. Cells were pulse labelled at 24 hpi with 1 μM EdU for 6h to label vDNA. (A, C)
Localization of eYFP.ICP4 (green), PML or IFI16 (cyan; as indicated) to vDNA (red) in newly infected cells on the periphery of a developing plaque-edge.
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HSV-1 ICP0-null mutant infection. As IFI16 binds to a range of DNA structures that may be
produced during vDNA replication [52], we next investigated the role of vDNA replication
in the induction of ISGs. ISG transcript levels were monitored in the presence of the vDNA
replication inhibitors PAA (phosphonoacetic acid) and ACG (acycloguanosine), two well-
characterized herpesvirus DNA replication inhibitors [53–57]. PAA efficiently inhibited the
induction of both Mx1 and ISG15 transcript levels in a dose-dependent manner (Fig 7E), while
ACG treatment had only a modest inhibitory effect at concentrations sufficient to restrict
HSV-1 plaque formation ( 50 μM; Fig 7F, S1 Table). Inhibition of ISG induction by PAA was
virus-specific, as ISG transcript levels were readily induced by IFN-β stimulation in the pres-
ence of PAA (Fig 7G). By way of contrast, JAK inhibition by Ruxolitinib (Ruxo) effectively
blocked ISG induction following IFN-β stimulation (Fig 7G; [58, 59]), consistent with a key
role for JAK in IFN-mediated innate immune signalling [60]. JAK inhibition also effectively
blocked ISG induction during HSV-1 ICP0-null mutant infection (Fig 7H). Importantly, this
inhibition occurred in the presence 50 μM ACG (Fig 7I), demonstrating that JAK activity is
specifically required to induce ISG expression during the initiating cycle(s) of HSV-1 ICP0--
null mutant vDNA replication by 9 hpi. Together with our microscopy observations (Fig 6),
these data demonstrate that the onset of vDNA replication is required for the robust induction
of ISG expression during HSV-1 ICP0-null mutant infection.
Dual roles for both PML and IFI16 in the regulation of intrinsic and innate
immunity to HSV-1 infection
As the induction of innate immunity during HSV-1 ICP0-null mutant infection was inhibited
by Ruxolitinib, we next examined the effect of JAK inhibition on WT and ICP0-null mutant
HSV-1 replication (Fig 8). At a concentration sufficient to inhibit ISG induction (5 μM; Fig
7G–7I), Ruxolitinib treatment had no effect on the relative plaque formation efficiency (PFE)
of either WT or ICP0-null mutant HSV-1 (Fig 8A). These data indicate that innate immune
signalling and the induction of ISGs does not directly contribute to the cellular restriction and
plaque-formation defect of an HSV-1 ICP0-null mutant observed in restrictive cell types
( 1000 fold; [33, 35, 61]). In contrast, virus yield assays demonstrated that Ruxolitinib treat-
ment enhanced the levels of ICP0-null mutant, but not WT, HSV-1 propagation (Fig 8B).
Thus, under infection conditions that saturate intrinsic host defences and enable the onset of
HSV-1 ICP0-null mutant replication (MOI of 1 PFU/cell; Fig 6E), innate immune defences
act to restrict virus propagation. By way of contrast, depletion of IFI16 or PML enhanced both
the PFE and virus yield of an HSV-1 ICP0-null mutant (Fig 8C and 8D; [11, 49]). Importantly,
Cut mask (yellow) highlights regions of colocalization between either PML or IFI16 and vDNA (as indicated). Weighted (w.) colocalization coefficients
shown. (B, D) Quantitation of PML and IFI16 recruitment to infecting vDNA in the presence or absence of eYFP.ICP4 at the nuclear rim (ICP4 NR and
ICP4 -ve, respectively; as shown in A and C). Boxes: 25th to 75th percentile range; black line: median weighted (w.) colocalization coefficient; whiskers: 5th to
95th percentile range. Solid line indicates coincident threshold level (weighted colocalization coefficients< 0.2). n = 100 plaque-edge cells +ve for vDNA
per PML or IFI16 sample population from 4 independent infections.  P< 0.001, ns (not significant), Mann-Whitney U-test. (E-I) Mx1 expression is only
induced under infection conditions that permit ΔICP0 plaque formation. (E) Number of plaques detected at 24 hpi following ΔICP0 infection of HFt cells
at an input MOI of 0.1 or 1 PFU/cell (as indicated). n = 3, means and standard deviations shown. (F) Quantitation of ΔICP0EdU nuclear genomes in HFt
cells (as infected in E). Boxes: 25th to 75th percentile range; black line: median; whiskers: 5th to 95th percentile range. n 250 cells derived from 3
independent experiments per condition. (G) Frequency of ΔICP0EdU genomes detected within infected cell nuclei (as described in E/F). Boxes: 25th to 75th
percentile range; black line: median; whiskers: minimum and maximum range of sample. (H) HFt cells were mock treated, IFN-β stimulated (100 IU/ml),
or infected with ΔICP0 at a MOI of 0.1 or 1 PFU/cell. Samples were fixed at 24 post-treatment and analysed by confocal microscopy for Mx1 (green) ISG
expression. (I) Quantitation of Mx1 positive cells (as shown in H). n 250 cells derived from 3 independent experiments per condition. (J) PML-NB
entrapment of vDNA is maintained under low MOI conditions (0.1 PFU/cell) that restrict ΔICP0EdU replication and plaque formation at 24 hpi. 3D
reconstruction of high-resolution Z-series confocal images showing PML entrapment of ΔICP0EdU vDNA. Single channel maximum intensity projection
images (left), 3D rendered images of the whole nucleus showing PML (green) and vDNA (red), with a single vDNA focus entrapped by PML (dashed box;
right). Scale bar 2 μm. Enlargement of PML entrapped vDNA (centre-right). Scale bar 0.5 μm. Cut mask (yellow) highlights colocalization between PML
and vDNA (far-right). Pearson coefficient for PML-vDNA colocalization shown. Nuclei were stained with DAPI (blue).
https://doi.org/10.1371/journal.ppat.1006769.g006
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Fig 7. Inhibition of vDNA replication impairs the induction of innate immunity during HSV-1 infection. HFt cells were mock, WT, or ΔICP0 HSV-1
infected at an MOI of 1 PFU/cell (unless stated otherwise). Samples were collected at the indicated times (hours; h) post-treatment or infection. (A) Relative
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no additional increase in virus yield was observed on Ruxolitinib treatment of IFI16 or PML
depleted cells (Fig 8D), indicative of an impaired innate immune response in these cells during
HSV-1 ICP0-null mutant infection. Correspondingly, qRT-PCR demonstrated that the induc-
tion of ISGs (Mx1, ISG15, ISG54) was significantly impaired in both IFI16 or PML depleted
cells in response to HSV-1 ICP0-null mutant infection at 9 hpi (Fig 8E and 8F). These data
identify a novel role for PML in the induction of ISGs and the regulation of innate immunity
during HSV-1 infection. Collectively, our data demonstrate that PML plays dual roles in the
temporal regulation of intrinsic and innate immune defences that are dependent on viral
genome delivery to the nucleus and the onset of vDNA replication, respectively.
As intrinsic and innate immune defences to HSV-1 infection are known to be cell-type
dependent [34, 35, 62], we next investigated if there was a correlation between cell line permis-
siveness to HSV-1 ICP0-null mutant replication and the entrapment of viral genomes by
PML-NB host factors (Fig 9). Relative to permissive osteosarcoma cells (U2OS, SAOS), which
do not require ICP0 to stimulate the onset of HSV-1 replication [34], RPE cells demonstrated
equivalent levels of HSV-1 ICP0-null mutant restriction to HFt cells ( 1000-fold reduction in
PFE, Fig 9A). Western blot analysis revealed that all these cell lines expressed similar levels of
PML, Daxx, and IFI16 (Fig 9B). However, infection with HSV-1EdU demonstrated a significant
reduction in the colocalization frequency of PML and Daxx to infecting viral genomes between
permissive (U2OS, SAOS) and restrictive (HFt, RPE) cell-types (Fig 9C and 9D). Importantly,
in many instances neither PML nor Daxx was observed to localize with infecting viral genomes
in permissive cell types (Fig 9C, bottom panels). Thus, we have identified a correlation between
the stable entrapment of vDNA by PML-NBs and the requirement for ICP0 to stimulate the
efficient onset of HSV-1 infection in restrictive (HFt, RPE), but not permissive (U2OS, SAOS),
cell-types. As U2OS and SAOS cells do not express ATRX (Fig 9B; [63, 64]), a known core con-
stituent protein of PML-NBs and an intrinsic antiviral regulator to HSV-1 infection [64–66],
we investigated the requirement for ATRX to mediate PML-NB entrapment of vDNA. HFt
cells were stably transduced with lentiviral vectors expressing non-targeting control or ATRX-
targeting short hairpin RNAs (shCtrl and shATRX, respectively; [65]). qRT-PCR and western
blotting confirmed ATRX depletion, which had a modest effect on PML mRNA transcript lev-
els without influencing PML or Daxx expression levels (Fig 9E and 9F). HSV-1EdU infection of
shCtrl or shATRX cells demonstrated that depletion of ATRX led to a distinct population of
viral genomes with a reduced colocalization frequency with PML (left-hand dotted box; Fig
9G). Notably, low levels of ATRX colocalization were still observed with vDNA in a significant
proportion of ATRX depleted cells (right-hand dotted box; Fig 9G). Quantitation (n 200
genomes per condition) revealed that there was a significant difference in PML recruitment to
vDNA in ATRX depleted cells (Fig 9H). We conclude that ATRX, either directly or indirectly,
contributes to the entrapment of vDNA within PML-NBs following nuclear entry.
mRNA levels of Mx1, ISG15, and ISG54 during WT or ΔICP0 HSV-1 infection. n = 2, means (RQ) and standard deviations (RQmin/max) are shown and
expressed relative to mock (1). (B) Western blot analysis of the expression levels of ISGs (ISG15, Mx1, ISG54), viral proteins (ICP0, ICP4, VP5), and actin
(as a loading control), from whole cell lysates of mock, IFN-β stimulated (100 IU/ml), WT or ΔICP0 HSV-1 infected HFt cells at the indicated times.
Molecular mass markers are shown. (C) Quantitation of ISG expression levels (as shown in B). n = 3, means and standard deviations shown expressed
relative to mock (1).  P< 0.01,  P< 0.001, ns (not significant); two-tailed t-test. (D) Relative mRNA levels of Mx1 and ISG15 in mock or ΔICP0
infected HFt cells (MOI of 0.01 to 1 PFU/cell, as indicated). n = 3, means (RQ) and standard deviations (RQmin/max) are shown and expressed relative to
ΔICP0 MOI 1 (1). (E, F) Relative mRNA levels of Mx1 and ISG15 in mock or ΔICP0 infected HFt cells in the presence of phosphonoacetic acid (PAA) or
acycloguanosine (ACG) at the indicated concentrations. n = 3, means (RQ) and standard deviations (RQmin/max) are shown and expressed relative to
ΔICP0 (1).  P< 0.05,  P< 0.01,  P< 0.001, ns (not significant); two-tailed t-test. (G) Relative mRNA levels of Mx1 and ISG15 in mock or IFN-β
stimulated (100 IU/ml) HFt cells co-incubated in the presence Ruxolitinib (5 μM; Ruxo) or PAA (1.6 mg/ml), as indicated. n = 2, means (RQ) and standard
deviations (RQmin/max) are shown and expressed relative to IFN-β treatment (1). (H, I) Relative Mx1 and ISG15mRNA levels in mock or ΔICP0 infected
HFt cells treated with Ruxo (2.5–10 μM, as indicated) or Ruxo (5 μM) and ACG (50 μM), as indicated. n = 2, means (RQ) and standard deviations (RQmin/
max) are shown and expressed relative to ΔICP0 infection (1).
https://doi.org/10.1371/journal.ppat.1006769.g007
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Finally, we compared restrictive (HFt, RPE) and permissive (U2OS, SAOS; [62]) cell types
to mount an innate immune response to HSV-1 ICP0-null mutant infection under infection
conditions that permitted the onset of viral replication (MOI 1 PFU/cell). Surprisingly,
qRT-PCR analysis demonstrated that only HFt cells induced ISG (Mx1, ISG15, ISG54) expres-
sion during HSV-1 ICP0-null mutant infection (Fig 10A, top panels; [62]). This was not due to
a defect in IFN pathway signalling, as all four cell-types were responsive to exogenous IFN-β
stimulation (Fig 10A, bottom panels). Correspondingly, only HFt cells showed enhanced levels
of HSV-1 ICP0-null mutant propagation following JAK inhibition by Ruxolitinib (Fig 10B).
We conclude that RPE cells, which are highly restrictive to HSV-1 ICP0-null mutant
Fig 8. Dual roles for PML and IFI16 in the regulation of intrinsic and innate immunity to HSV-1 infection. (A) HFt cells were DMSO or Ruxolitinib
(5μM; Ruxo) treated and infected with serial dilutions of WT or ΔICP0 HSV-1 for 24 h prior to immuno-staining for plaque formation. Plaque counts
expressed relative to control cell monolayers (# of plaques treated / # of plaques DMSO control) at equivalent serial dilutions of virus and presented as
relative plaque formation efficiency (PFE). n 3, means and standard deviations shown. (B) HFt cells were DMSO or Ruxo treated and infected with WT
(MOI 0.001 PFU/cell) or ΔICP0 (MOI 1 PFU/cell) HSV-1. Cell released virus (CRV) was harvested at the indicated times (hpi) and CRV titres determined
on U2OS cells. n = 3, means and standard deviations shown. (C) Stably transduced HFt cells expressing non-targeting control (shCtrl), or targeting IFI16
(shIFI16) or PML (shPML) shRNAs, were infected with WT or ΔICP0 HSV-1 (as in A). Plaque counts expressed relative to infected shCtrl cell monolayer
plaque counts (1) and presented as relative PFE. n = 3, means and standard deviations shown. (D) shCtrl, shIFI16, or shPML HFt cells were treated with
DMSO or Ruxo and infected with either WT or ΔICP0 HSV-1 (as in B). CRV was collected at the indicated times (hpi) and titres determined on U2OS
cells. n = 3, means and standard deviations shown. (E, F) Relative Mx1, ISG15, and ISG54mRNA levels in HFt shCtrl, shIFI16, or shPML cells mock or
ΔICP0 infected (MOI 1 PFU/cell) at 9 hpi. n = 3, means (RQ) and standard deviations (RQmin/max) shown and expressed relative to ΔICP0 infected shCtrl
(1).  P< 0.001; two-tailed t-test.
https://doi.org/10.1371/journal.ppat.1006769.g008
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Fig 9. PML-NB entrapment of infecting HSV-1 vDNA occurs in a cell type and ATRX dependent manner. (A) U2OS, SAOS, RPE, and HFt cells were
infected with serial dilutions of WT or ΔICP0 HSV-1 for 24 h. Plaque counts expressed relative to U2OS, a cell line permissive to ΔICP0 replication [34], (#
of plaques / # of plaques U2OS control) at equivalent serial dilutions of virus and presented as relative plaque formation efficiency (PFE). n 3, means and
standard deviations shown. (B) Western blot analysis of the relative expression levels of PML, Daxx, ATRX, and IFI16 in whole cell lysates derived from
HFt, RPE, U2OS and SAOS cells. Actin is shown as a loading control. Molecular mass markers are indicated. (C) Localization of PML (green) and Daxx
(cyan) to HSV-1EdU vDNA (red, white arrows) in restrictive (HFt, RPE) and permissive (U2OS, SAOS) cell types at 30 mpi (post-addition of virus; MOI of
3 PFU/cell). Insets show magnified regions of interest (dashed boxes) highlighting host protein localization with vDNA. Cut mask (yellow) highlights
regions of colocalization between PML, Daxx, and vDNA (as indicated). Weighted (w.) colocalization coefficients shown. (D) Quantitation of PML and
Daxx recruitment to infecting vDNA in restrictive (HFt, RPE) and permissive (U2OS, SAOS) cell lines (as shown in C). Boxes: 25th to 75th percentile range;
black line: median weighted (w.) colocalization coefficient; whiskers: 5th to 95th percentile range. Solid line indicates coincident threshold level (weighted
colocalization coefficients< 0.2). n 50 vDNA foci per sample population from 4 independent infections. (E-H) ATRX is required for efficient PML-NB
Temporal regulation of intracellular immunity to HSV-1 infection
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006769 January 8, 2018 18 / 36
replication (Fig 9A), are defective in aspects relating to intracellular innate signalling in
response to HSV-1 infection. These data support our microscopy observations (Fig 6) and
inhibitor studies (Figs 7 and 8), and collectively demonstrate that intrinsic and innate host
immune responses to HSV-1 infection are temporally distinct and functionally separable arms
of host immunity.
In summary, we show that the temporal recruitment of host immune regulators to infecting
viral genomes plays an important role in the sequential regulation of intrinsic and innate
immunity during HSV-1 infection. We identify PML-NBs to entrap vDNA shortly after
nuclear entry in an ATRX-dependent and IFI16-independent manner. We identify a novel
role for PML in the induction of innate immunity in response to HSV-1 infection that corre-
lates with the recruitment of IFI16 into vDNA complexes associated with ICP4 and the onset
of vDNA replication. These intracellular host defences are counteracted by ICP0, which
entrapment of vDNA. HFt cells were stably transduced with lentiviruses expressing ATRX-targeting (shATRX) or non-targeting control (shCtrl) shRNAs.
(E) qRT-PCR quantitation of ATRX or PML mRNA levels in HFt shCtrl and shATRX cells. Mean (RQ) and standard deviation (RQmin/max) shown and
expressed relative to HFt shCtrl cells (1). (F) Western blot analysis of the relative expression levels of ATRX, PML, and Daxx in whole cell lysates from HFt
shCtrl and shATRX cells. Actin is shown as a loading control. Molecular mass markers are shown. (G) Scatter plot showing paired w. colocalization
coefficients of ATRX and PML to individual nuclear infecting viral genomes in shCtrl (blue) and shATRX (red) cells infected with HSV-1EdU at an MOI of
3 PFU/cell at 90 mpi (post-addition of virus). n 200 genomes per sample population. Dotted boxes highlight genome populations identified to have
altered distribution of colocalization frequency in comparison to infected shCtrl cells. (H) Quantitation of PML and ATRX recruitment to infecting viral
genomes (as shown in G). Boxes: 25th to 75th percentile range; black line: median weighted (w.) colocalization coefficient; whiskers: 5th to 95th percentile
range. Solid line indicates coincident threshold level (weighted colocalization coefficients< 0.2).  P< 0.05,  P< 0.001; Mann-Whitney U-test.
https://doi.org/10.1371/journal.ppat.1006769.g009
Fig 10. PML-NB entrapment of vDNA does not lead to the induction of innate immunity. (A) Relative Mx1, ISG15, and ISG54mRNA levels in cell lines
restrictive (HFt, RPE) or permissive (U2OS, SAOS) to HSV-1 ICP0-null mutant (ΔICP0) infection. Cells were mock treated, IFN-β (100 IU/ml) stimulated,
or infected with ΔICP0 at an MOI of 1 PFU/cell for 9 h. n = 3, means (RQ) and standard deviations (RQmin/max) are shown and expressed relative to
mock for each cell line (1). (B) Restrictive (HFt, RPE) or permissive (U2OS, SAOS) cell lines were infected with ΔICP0 at an MOI of 1 PFU/cell and treated
with either DMSO or Ruxolitinib (Ruxo, 5μM). CRV was harvested at 48 hpi and titres determined on U2OS cells. n = 3, means and standard deviations
shown and expressed as relative fold-change to DMSO titres (1) for each cell line.  P< 0.05,  P< 0.001, ns (not significant); two-tailed t-test.
https://doi.org/10.1371/journal.ppat.1006769.g010
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induces the degradation of PML from the outset of infection to release viral genomes
entrapped within PML-NBs to stimulate the onset of HSV-1 lytic replication.
Discussion
A key aspect in the regulation of intracellular host immunity during herpesvirus infection is
the rapid recruitment of host immune factors to infecting viral genomes. This nuclear response
to infection has been linked to viral genome silencing, as part of a pre-existing intrinsic
immune defence, and the activation of innate immune signalling pathways (reviewed in [1, 4,
32]). However, the temporal recruitment of these host immune regulators to infecting viral
genomes upon vDNA entry into the nucleus has remained poorly defined due to the technical
challenges associated with low genome copy-number detection.
Microscopy studies have historically relied on the use of viral mutants, high MOI condi-
tions, and vDNA binding proteins to investigate the recruitment of host immune regulators to
infecting viral genomes. Whilst informative, such approaches can readily saturate intrinsic
host defences that restrict the initiation of viral gene expression due to high input genome
loads [35]. Consequently, the temporal sequence of events that influence the sequential regula-
tion of intracellular host immunity upon vDNA entry into the nucleus has remained poorly
defined, specifically during WT herpesvirus infections that express a full complement of
immune antagonists. Here we quantitatively examine the recruitment of intrinsic and innate
immune regulators to infecting WT and ICP0-null mutant HSV-1 genomes under a range of
relatively low MOI conditions ( 3 PFU/cell) within the first 15–90 mpi (post-addition of
virus). We show that PML, the principle scaffolding protein of PML-NBs [48], plays tempo-
rally distinct and functionally separable roles in the regulation of intrinsic and innate immune
defences activated in response to HSV-1 infection through the entrapment of viral genomes
(Figs 2 and 6) and the induction of ISG expression following the onset of vDNA replication
(Fig 7), respectively. These observations reconcile many longstanding issues within the field as
to the importance of PML and PML-NBs during primary herpesvirus infection and the
requirement for ICP0 to stimulate the onset of HSV-1 lytic replication, as discussed below.
Immuno-FISH experiments conducted by Gerd Maul and colleagues over 20 years ago
originally identified that infecting HSV-1 genomes localize in close proximity to PML-NBs
under infection conditions that enabled detection of ICP8 [8], an essential component of the
vDNA replication complex [67]. These pioneering observations have stimulated a field of
research that has uncovered fundamental roles for many PML-NB associated proteins in the
regulation of intracellular host immunity against a range of DNA and RNA viral pathogens
(reviewed in [1, 20, 21, 68]). PML-NBs are highly dynamic nuclear sub-domains, with resident
proteins (PML, Sp100, and Daxx) in constant exchange with the surrounding nucleoplasm
[10]. Correspondingly, asynchronous plaque-edge recruitment assays (examples of which are
shown in Fig 6, S7 Fig; [9]) have shown that many PML-NB component proteins re-localize to
sites in close proximity to infecting HSV-1 genomes under high MOI conditions, where de
novo PML-NB like foci are reformed [10]. These observations have set the paradigm for intrin-
sic immunity during herpesvirus infection, where pre-existing PML-NB host factors re-localize
to infecting viral genomes to mediate the transcriptional repression of viral gene expression
[19, 49, 50, 69]. However, recent live-cell microscopy studies have proposed an alternate mech-
anism, whereby vDNA becomes transiently associated with host factor(s) within the nucleo-
plasm (notably Daxx and IFI16; [12, 14]) prior to deposition at PML-NBs, although no
evidence for Daxx or IFI16 colocalization with vDNA or deposition within PML-NBs was
reported. Using click chemistry, we demonstrate for the first time that infecting WT and
ICP0-null mutant HSV-1 genomes are rapidly entrapped within PML-NBs following nuclear
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entry (30–90 mpi; Figs 2 and 6J). While we cannot rule out a recruitment model of genome
entrapment, specifically the re-localization of PML-NB host factors that are in immediate
proximity to nuclear infecting viral genomes, our data support a deposition model as: (i)
PML-NBs that contained vDNA were indistinguishable in composition from other PML-NBs
within the same infected nucleus or mock-infected cells (Fig 3A–3D, S3 Fig); (ii) Depletion of
PML reduced Daxx colocalization with vDNA, indicative of a transient association stabilized
by PML at PML-NBs where Daxx is a resident protein (Fig 4E; [48, 49]); (iii) Depletion of
ATRX, a binding partner of Daxx [70], reduced the frequency of PML colocalization with
vDNA in a significant subset of infected cells (Fig 9E–9H). These observations support a depo-
sition model of vDNA entrapment at pre-existing PML-NBs that contain a core complement
of PML-NB host factors and implicate the Daxx/ATRX complex in this process, consistent
with live-cell microscopy observations [12]. These observations are consistent with co-deple-
tion experiments [19, 50, 69], which have shown PML-NB proteins to act cooperatively to
restrict the initiation of HSV-1 ICP0-null mutant replication under low MOI conditions ( 1
PFU/cell, 6E; < 25 genome copies/cell, S2 Table). We therefore provide spatial context to these
studies, as repressed viral genomes remain stably entrapped within PML-NBs at 24 hpi (Fig
6J), a host response that is impaired in cell types permissive to HSV-1 ICP0-null mutant repli-
cation which lack ATRX (U2OS, SAOS; Fig 9A–9D; [34, 63, 64]). Thus, we identify PML-NB
entrapment of vDNA as a key intrinsic antiviral host defence to WT herpesvirus nuclear infec-
tion, a conclusion consistent with genome localization studies in HSV-1 latently infected cells
by immuno-FISH [71–73]. We demonstrate that this intrinsic PML-NB host defence occurs in
a range of restrictive cell types relevant to primary HSV-1 infection (Figs 2 and 9) and inde-
pendently of the induction of ISG expression (Figs 6H–6J, 7D and 10A), demonstrating that
this host response does not directly contribute to the sensing of viral nucleic acids that leads to
the induction of innate immunity.
Our data highlights the importance of ICP0 to promote the onset of WT HSV-1 infection
under low MOI conditions [33–35]. ICP0 is known to localize to PML-NBs from the outset of
infection in a PML isoform and SUMO-dependent manner [17, 22, 74, 75], where it targets
PML and other SUMO-modified component proteins for ubiquitination and proteasome-
dependent degradation [17, 25–27, 74, 75]. As ICP0 does not preferentially localize to PML-
NBs that contain vDNA (Fig 2C), our data indicate that these vDNA containing nuclear bodies
are likely to be equivalent in their respective PML isoform composition and SUMO modi-
fication status at this extremely early stage of nuclear infection. Thus, cell-wide PML-NB dis-
ruption through ICP0 mediated degradation of PML ensures viral genome release and the
dispersal of associated PML-NB host factors that repress the onset of viral gene expression [19,
49, 50, 66, 69]. This hypothesis is supported by our depletion experiments that show reduced
Daxx localization with vDNA in PML depleted cells (Fig 4E), and accounts for why many
PML-NB resident host factors known to restrict HSV-1 ICP0-null mutant replication (includ-
ing Daxx, ATRX, and PIAS1) are not directly targeted for degradation by ICP0 [19, 66]. Thus,
the correct complement of host factors within pre-existing PML-NBs is likely to play an
important role in mediating the cellular restriction of viral gene expression from the outset of
nuclear infection. These observations account for why many herpesviruses encode IE gene
products that disrupt the structural organization of PML-NBs (reviewed in [1, 68]), and the
respective abilities of these proteins to complement the replication and plaque-forming defect
of an HSV-1 ICP0-null mutant in restrictive cell types [76–79].
Our observation that repressed HSV-1 ICP0-null mutant genomes remain stably entrapped
within PML-NBs without inducing ISG expression (Figs 6E–6J and 7D) has significant impli-
cations with respect to host PRR sensing of vDNA and the regulation of innate immunity dur-
ing herpesvirus infection. The sensing of foreign DNA and the activation of innate immune
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signalling pathways can occur through multiple pathways and PRRs, including TLR9, RIG-I,
MAVS, AIM2, DNA-PK, cGAS, and IFI16 (reviewed in [4–6]). Of these, IFI16 has received
significant attention due to its role as a vDNA PRR in the induction of ISG expression and
type-I IFN production during herpesvirus infection [28, 29, 80–84]. Correspondingly, micros-
copy assays have shown IFI16 to be recruited to infecting HSV-1 genomes in a pyrin domain-
dependent manner in association with PML-NB host factors [11, 12, 14]. This host response
was initially reported to be antagonized by the ubiquitin ligase activity of ICP0 [28, 29],
although subsequent studies have shown other viral and cellular factors are likely to be
involved [11, 30, 31]. IFI16 recruitment studies have relied on the use of vDNA binding pro-
teins to enable viral genome detection by proxy, or on extrapolation of altered patterns in
IFI16 nuclear localization to infer IFI16-vDNA association in restrictive cell types. Thus, the
temporal kinetics of IFI16 recruitment to vDNA and its subsequent association with PML-NB
host factors has remained poorly defined, specifically under MOI conditions relevant to WT
herpesvirus infections. In contrast to PML-NB host factors, we failed to observe any significant
frequency of stable colocalization between IFI16 and vDNA up to 90 mpi (post-addition of
virus; Figs 3 and 5, S5 Fig), even in the absence of PML or ICP0 (Fig 4E). While we cannot
exclude the possibility of highly transient IFI16 interactions with vDNA (S5A Fig; [12, 14]),
our data indicates that IFI16 does not play an essential role in the entrapment of viral genomes
by PML-NBs (Fig 5; [11, 14]). Importantly, under infection conditions that do not saturate or
antagonize intrinsic PML-NB host defences (HSV-1 ICP0-null mutant MOI < 1 PFU/cell, Fig
6E; < 25 genome copies/cell, S2 Table), we demonstrate vDNA entry into the nucleus alone is
not sufficient to stimulate a robust innate immune response (Figs 6E–6J and 7D). Induction of
innate immunity only occurred under MOI conditions sufficient to saturate intrinsic host
defences leading to the onset of HSV-1 ICP0-null mutant replication and plaque-formation
(MOI 1 PFU/cell; Figs 6E and 7D). Under such conditions, we identified a clear kinetic dif-
ference in the stable recruitment of PML and IFI16 to infecting viral genomes, which in the
case of IFI16 correlated with the recruitment of ICP4 (the major IE viral transcription factor)
to vDNA and the onset of viral gene expression (Fig 6A–6D). Thus, we have identified a tem-
poral boundary in the recruitment of intrinsic and innate immune regulators to infecting viral
genomes that could represent a shift in host response; from an intrinsic defence centred on the
repression of viral gene expression to the induction of innate immune signalling that promotes
an antiviral state to restrict virus propagation. This hypothesis is supported by our observation
that the induction of innate immunity requires the onset of vDNA replication (Fig 7E and 7I).
IFI16 is reported to recognise nucleosome free DNA in a sequence independent manner [85–
87], with high binding affinity for G quadraplex, branched or cruciform DNA structures [52].
Thus, it likely that the recruitment of IFI16 to infecting viral genomes is stabilised following
the onset of vDNA replication that produces an abundance of such DNA structures [57]. This
hypothesis may account for why PAA, but not ACG, is capable of inhibiting the induction of
ISG expression (Fig 7E and 7F). As inactivation of the vDNA polymerase by PAA would be
expected to impair the initiation of vDNA replication [53, 57], while ACG treatment would
lead to the accumulation of stalled vDNA replication products [54]. Thus, we hypothesize that
the topology of replicating vDNA is important for the stable recruitment of IFI16 on to vDNA
that leads to the induction of ISG expression and type-I IFN production during herpesvirus
infection. We note that other viral and cellular factors are likely to contribute to the induction
of innate immunity under alternative infection conditions, for example excessively high MOI,
UV inactivation, or the use of viral mutants defective in multiple genes, which may deliver or
generate PAMPs for PRR detection at different stages of infection.
While it is clear that IFI16 plays a key role in the induction of ISG expression during her-
pesvirus infection, we have also identified an important and novel role for PML in this host
Temporal regulation of intracellular immunity to HSV-1 infection
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006769 January 8, 2018 22 / 36
response to HSV-1 infection (Fig 8). Depletion of PML significantly reduced the levels of ISG
transcript accumulation observed at 9 hpi during HSV-1 ICP0-null mutant infection (Fig 8F),
a time point which proceeds ISG expression (16 hpi; Fig 7B). Thus, under infection conditions
that saturate intrinsic PML-NB host defences during HSV-1 ICP0-null mutant infection
(MOI 1 PFU/cell, ~ 25 genome copies/cell), PML plays a significant role in mediating the
induction of ISG transcription. Correspondingly, pharmacological inhibition of JAK signalling
by Ruxolitinib [58, 59] did not enhance HSV-1 ICP0-null mutant propagation in either IFI16
or PML depleted cells (Fig 8D). Collectively, these data demonstrate that PML plays an impor-
tant role in the induction of innate immunity in response to HSV-1 infection that restricts the
propagation of HSV-1 following the successful saturation of PML-NB intrinsic host defences.
These observations are consistent with reports highlighting a role for PML to mediate the
induction of innate immunity in response to other human herpesviruses [88–90], and a grow-
ing body of literature suggesting that specific PML isoforms play an important role in mediat-
ing the transcriptional regulation of cytokine signalling (reviewed in [91]). Notably, PML has
been reported to mediate the recruitment of activated STAT1 and 2, along with HDAC1 and
2, onto ISG promoters (ISG54, CXCL10) during human cytomegalovirus (HCMV) infection
[90]. This host response is antagonized by the HCMV IE gene product IE1 [88, 90], a viral pro-
tein known to disrupt PML-NBs and to relieve the intrinsic cellular restriction of an HSV-1
ICP0-null mutant [78]. As JAK activity is well known to be required for STAT phosphoryla-
tion [60], these observations are consistent with our inhibitor studies (Figs 7H, 7I, 8B and 8D),
which show JAK activity to play an important role in the induction of ISGs during HSV-1
ICP0-null mutant vDNA replication at 9 hpi. Consistent with STAT1 depletion studies [61],
JAK inhibition did not influence the intrinsic restriction of an HSV-1 ICP0-null mutant (Fig
8A). These data contrast with depletion studies, which show a clear cooperative role for
PML-NB host factors to restrict the initiation of HSV-1 ICP0-null replication [19, 50, 69].
Taken together with our observations in RPE cells (Figs 9A and 10), which are restrictive to
ICP0-null HSV-1 replication but defective in innate immune signalling, these data show that
PML plays dual roles in the temporal regulation of both intrinsic and innate immunity in
response to HSV-1 infection. Host defences that are counteracted by ICP0 through the degra-
dation of PML and disruption of PML-NBs from the outset of infection.
In conclusion, we have shown for the first time that the differential recruitment of host
immune regulators to infecting viral genomes plays a fundamental role in the sequential regu-
lation of intrinsic and innate immune defences following HSV-1 nuclear infection. We have
identified dual roles for PML in the regulation of these intracellular defences to HSV-1 infec-
tion that are dependent on vDNA entry into the nucleus and the onset of vDNA replication,
respectively. Our analysis reconciles many long-standing questions as to the importance of
PML and PML-NBs in the regulation of intracellular host immunity during HSV-1 infection.
Our data highlights the importance of viral antagonists that disrupt PML-NBs to inactivate
and evade key intracellular immune defences from the outset of infection, thereby promoting
the onset of replication, propagation, and ultimately transmission to new hosts. Moreover, we
demonstrate the versatility and sensitivity of bio-orthogonal labelling of viral nucleic acid to
investigate the temporal recruitment of host immune regulators to infecting viral genomes
during infection.
Materials and methods
Cells and drugs
Primary human foreskin fibroblast cells (HFs) were obtained from Thomas Stamminger
(Department of Urology, University of Erlangen; [49]) and immortalized (HFt) by retrovirus
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transduction to express the catalytic subunit of human telomerase, as previously described
[18]. HFt, retinal pigmented epithelial (RPE-1; ATCC, CRL-4000), Human osteosarcoma
(U2OS and SAOS; ECACC, 92022711 and 89050205), primary human foetal lung fibroblast
(MRC-5; ATCC, CCL-171), and adult human keratinocyte (HaCat; a gift of F. Rixon,
MRC-UoG CVR) cells were grown in Dulbecco’s Modified Eagle Medium (DMEM; Life Tech-
nologies, 41966). HFt cells were cultured in the presence of 5 μg/ml of Hygromycin (Invitro-
gen, 10687–010) to maintain hTERT expression. Transduced HFt cells expressing shRNAs
were cultured in the presence of Puromycin (Sigma-Aldrich, P8833; 1 μg/ml or 0.5 μg/ml for
selection or maintenance, respectively). Primary human embryonic lung fibroblast (HEL 299;
ECACC, 87042207) cells were maintained in Minimum Essential Medium Eagle (MEM;
Sigma-Aldrich M5650) supplemented with 2 mM L-Glutamine (Life Technologies, 25030–
024) and 1 mM Sodium Pyruvate (Life Technologies, 11360–039). Baby hamster kidney fibro-
blast (BHK-21 C13; a gift of R. Everett, MRC-UoG CVR) cells were grown in Glasgow Mini-
mum Essential Medium (GMEM; Life Technologies, 21710–025) supplemented with 10%
Tryptose Phosphate Broth (TPB; Life Technologies, 18050–039). Medium for all cell lines was
supplemented with 10% foetal bovine serum (FBS; Life Technologies, 10270), 100 units/ml
penicillin, and 100 μg/ml streptomycin (Life Technologies, 15140–122). All cell lines were
maintained at 37˚C in 5% CO2. 5-Ethynyl-2’-deoxyuridine (EdU; Sigma-Aldrich, T511285),
5-Ethynyl-2’-deoxycytidine (EdC; Sigma-Aldrich, T511307), 2’-deoxyruridine (dU; Sigma-
Aldrich, D5412), and Ruxolitinib (Ruxo; Sellechchem, S1378) were prepared in DMSO and
used at the indicated concentrations. Acycloguanosine (ACG, Sigma-Aldrich, A4669), Phos-
phonoacetic acid (PAA, Sigma-Aldrich, 284270), and Interferon beta (IFN-β; Calbiochem,
407318) were prepared in Milli-Q H2O and used at the indicated concentrations.
Viruses
Wild-type HSV-1 strain 17syn+ (HSV-1), its ICP0-null mutant derivative dl1403 (ΔICP0;
[33]), and their respective variants that express eYFP.ICP4 [40] were propagated and titrated
as described [35]. For EdU labelling of viral genomes, RPE cells were infected with either
HSV-1 (MOI 0.001 PFU/cell) or ΔICP0 (MOI 0.5 PFU/cell). At 24 h post-infection (hpi), EdU
or EdC was added at a final concentration of 0.5 μM, unless otherwise indicated. Fresh EdU/
EdC was pulsed into infected cultures at 24 h intervals until extensive cytopathic effect was
observed, typically 3 to 4 days post-infection. Supernatants containing labelled cell released
virus (CRV) were clarified by centrifugation (423 xg for 10 min) and filtered through a
0.45 μm sterile filter and pelleted using a Beckman TLA100 Ultracentrifuge (33,800 xg for 3h
at 4˚C). Virion pellets were resuspended and pooled in 500 μl complete DMEM medium, and
titrated in U2OS cells as described [35].
Plasmids and lentiviral transduction
Plasmids encoding short hairpin (sh) RNAs against a non-targeted control sequence (shCtrl;
5’-TTATCGCGCATATCACGCG-3’), PML (shPML; 5’-AGATGCAGCTGTATCCAAG-3’),
ATRX (shATRX; 5’- CGACAGAAACTAACCCTGTAA-3’), or IFI16 (shIFI16; 5’-CCAC
AATCTACGAAATTCA-3’) were used to generate lentiviral supernatant stocks for transduc-
tion of HFt cells as described [11, 49, 65]. Pooled and stably transduced cells were used for
experimentation.
Antibodies
The following antibodies were used for immunofluorescence or western blotting: Primary rab-
bit polyclonal: anti-actin (Sigma-Aldrich, A5060), anti-Daxx (Upstate, 07–471), anti-ATRX
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(Santa Cruz, H300), anti-PML (Bethyl Laboratories, A301-167A; Jena Biosciences, ABD-030),
anti-Sp100 (GeneTex, GTX131569), anti-SUMO2/3 (Abcam, ab22654), anti-Mx1 (Santa Cruz,
sc-50509;ProteinTech, 13750-1-AP), anti-ISG15 (ProteinTech, 15981-1-AP), and anti-ISG54
(IFIT2, proteinTech, 12604-1-AP). Primary mouse monoclonal: anti-ICP0 (11060, [92]), anti-
ICP4 (58s, [93]), anti-VP5 (DM165, [94]), anti-SUMO2/3 (Abcam, ab81371), anti-PML
(abcam, ab96051), anti-IFI16 (abcam, ab55328; Santa Cruz, sc-8023). Primary antibodies were
detected using the following secondary antibodies: DyLight-680 or -800 conjugated anti-rabbit
or -mouse (Thermo; 35568 and SA5-35571), Alexa -488, -555, or -647 conjugated anti-rabbit,
or -mouse (Invitrogen; A21206, A21202, A31572, A31570, A31573, A31571), HRP conjugated
anti-mouse (Sigma-Aldrich, A4416).
Plaque Forming Efficiency (PFE)
Unless otherwise stated, cells were infected with serial dilutions of HSV-1 or ΔICP0 and
rocked every 10 min for 1 h prior to overlay with medium supplemented with 2% Human
Serum (HS; MP Biomedicals, 2931149). 24 to 36 hpi, cells were washed twice in PBS (Sigma-
Aldrich, D1408), simultaneously fixed and permeabilized in 1.8% formaldehyde (Sigma-
Aldrich, F8775) and 0.5% NP40 (BDH, 56009) in PBS for 10 min, then washed twice in 0.1%
Tween in PBS (PBST). Cells were blocked with 5% skimmed milk powder (SMP; Marvel) in
PBST (blocking buffer) for 30 min before incubation with an anti-VP5 monoclonal antibody
diluted in blocking buffer for 90 min. Cells were washed three times with PBST, incubated
with HRP conjugated anti-mouse IgG diluted in blocking buffer for 60 min, then washed with
PBST three times. Plaques were visualized with True Blue peroxidase developing solution
(Insight, 50-78-02) according to the manufacturer’s instructions, and washed with Milli-Q
H2O prior to plaque counting or imaging using an Axio Observer Z.1 microscope (Zeiss) with
differential interference contrast. For plaque formation efficiency (PFE) assays, plaque counts
are expressed relative to the number of plaques on control HFt or U2OS infected cell monolay-
ers (as indicated) at the equivalent dilution of input virus. Results presented as relative fold
change (number of plaques sample/number of plaques sample control). Plaque diameters were
measured using Zen blue (Zeiss) imaging software.
Viral yield assays
Cells were infected with either HSV-1 (MOI 0.001 PFU/cell), or ΔICP0 (MOI 1 or 2 PFU/cell,
as indicated) and rocked every 10 min for 1 h prior to overlay with complete medium contain-
ing either 5 μM Ruxolitinib or DMSO as a carrier control. Supernatants containing cell
released virus (CRV) were collected at the indicated times post-infection. Virus titres were cal-
culated by titration on U2OS cells as described [35].
Particle counting
Equal volumes of virus suspension and polystyrene latex spheres (Agar Scientific, AGS130-02)
at a known concentration per ml were mixed in 2 volumes of TNE buffer (20 mM Tris [pH
7.5], 0.5 M NaCl, and 1 mM EDTA). 5 μl of suspension was then added to a glow discharged
EM grid (Agar Scientific, S162-4), allowed to rest for 1 min, washed three times in deionised
water, and stained with Ammonium Molybdate (2% (w/v) pH 7.2). Dry grids were examined
using a JEM2200 FS electron microscope (JEOL) and images captured using an Ultrascan
4000 charge-coupled-device (CCD) camera (Gatan). Multiple images (n 6) per sample were
used for virus particle and latex bead enumeration and used to calculate the number of parti-
cles per ml of virus stock inoculum.
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Western blotting
Treated or infected cells were washed twice with PBS. Whole cell lysates were collected in
SDS-PAGE loading buffer containing 4 M Urea (Sigma-Aldrich, U0631) and 50 mM Dithio-
threitol (DTT; Sigma-Aldrich, D0632). Proteins were resolved on NuPAGE 4–12% Bis-Tris
Protein gels (Invitrogen, NP0322BOX) in MES (Invitrogen; NP0002) or MOPS buffer (Invi-
trogen, NP0001) and transferred onto 0.2 μm nitrocellulose membrane (Amersham,
15249794) for 90 min at 30 volts in Novex transfer buffer (Invitrogen, NP0006-1) according to
the manufacturer’s instructions. Membranes were blocked in PBS with 5% FBS (Block) for a
minimum of 1 h at room temperature. Membranes were incubated in primary antibody
diluted in Block for a minimum of 1 h, washed three times with PBST for 5 min each, then
incubated in secondary antibody diluted in Block for 1 h. Following three 5 min washes in
PBST, one 5 min wash in PBS, and one rinse in Milli-Q H2O, membranes were imaged on an
Odyssey Infrared Imager (LiCor). The intensity of protein bands was quantified with Odyssey
Image Studio Software.
Immunofluorescence and confocal microscopy
Cells were seeded overnight on to 13 mm coverslips prior to treatment or infection at the indi-
cated MOI and time points at 37˚C. For click chemistry assays, cells were washed in serum
free DMEM prior to overlay in complete medium or fixation. At indicated time points, cells
were washed twice in CSK buffer (10 mM HEPES, 100 mM NaCl, 300 mM Sucrose, 3 mM
MgCl2, 5 mM EGTA), simultaneously fixed and permeabilized in 1.8% formaldehyde and
0.5% Triton-X100 (Sigma-Aldrich, T-9284) in CSK buffer for 10 min, and washed twice in
CSK. Coverslips were then blocked with 2% HS in PBS for 30 min prior to click chemistry fol-
lowed by immunostaining. Where applicable, EdU-labelled vDNA was detected using the
Click-iT Plus EdU Alexa Fluor 555 Imaging Kit (ThermoFisher scientific, C10638) according
to the manufacturer’s instructions. For host and viral protein labelling, cells were incubated
with primary antibodies diluted in 2% HS in PBS for 60 min, then washed in PBS three times,
before incubation with secondary antibodies and DAPI (Sigma-Aldrich, D9542) in 2% HS in
PBS for 60 min. Coverslips were then washed in PBS three times, and twice in Milli-Q H2O
prior to mounting on Citiflour AF1 (Agar Scientific, R1320). Coverslips were examined using
a Zeiss LSM 880 confocal microscope using the 63x Plan-Apochromat oil immersion lens
(numerical aperture 1.4) using 405 nm, 488 nm, 543 nm, 594 nm, and 633 nm laser lines. Zen
black software (Zeiss) was used for image capture, generating cut mask channels, and calculat-
ing weighted colocalization coefficients. High-resolution Z-series images were captured under
LSM 880 Airy scan deconvolution settings using 1:1:1 capture conditions at 0.035 μm intervals.
Images were processed using Imaris (Bitplane) software to produce rendered 3D image recon-
structions and to calculate Pearson colocalization coefficients. Exported images were processed
with minimal adjustment using Adobe Photoshop and assembled for presentation using
Adobe Illustrator.
Virion genome release assay
In vitro virion DNA release assays were conducted as essentially described in [47]. Briefly,
1x108 PFU of virus preparation was diluted in ice-cold TNE buffer in the presence or absence
of GuHCl (2M final concentration; Sigma-Aldrich, G3272). Samples were incubated on ice for
60 mins prior to the addition of ice-cold Methanol (final concentration 60%). Samples were
dried onto poly-D-lysine (Sigma-Aldrich, P7405) treated coverslips for 60–90 mins at 4˚C
prior to fixation in PBS containing 1.8% formaldehyde and 0.5% Triton-X100 for 10 mins at
RT. Samples were washed twice in PBS and blocked in PBS containing 2% FBS for 10 mins at
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RT. Samples were processed for click chemistry to detect EdU or EdC labelled vDNA and
immuno-stained for VP5 to detect viral capsids (as described above). High-resolution Z-series
images were captured under LSM 880 Airy scan deconvolution settings at 0.2 μm intervals (as
described above) and the number of capsids and EdU or EdC labelled viral genomes were
quantified in Zen blue (Zeiss) from maximum intensity projection images.
Plaque-edge recruitment assays
HFt cells were infected with ΔICP0 EYFP.ICP4 at an MOI of 2 PFU/cell to enable the initiation
of viral replication and plaque formation, as previously described [9]. At 24 hpi, infected cell
monolayers were pulsed with 1 μM EdU for 6h prior to fixation and immunostaining, as
described above.
Quantitative RT-PCR
Cells were mock, HSV-1, or ΔICP0-infected at the indicated MOI, and total RNA collected at
9 hrs post-infection unless otherwise stated. Where applicable, all drug treatments were added
at the indicated concentration 1 h after inoculum adsorption. Total RNA was isolated using
the RNAeasy Plus Kit (Qiagen, 74134) according to the manufacturer’s instructions. Reverse
transcription (RT) was performed using the TaqMan Reverse Transcription Reagents kit (Life
Technologies, N8080234) with oligo(dT) primers. cDNA samples were analyzed in triplicate
using TaqMan Fast Universal PCR Master Mix (Life Technologies, 4352042) with the follow-
ing TaqMan gene specific primer-(FAM/MGB) probe mixes (Life Technologies): PML (assay
ID Hs00231241_m1), IFI16 (assay ID Hs00986757_m1), ATRX (assay ID HS00997529_m1),
Mx1 (assay ID HS00895608_m1) ISG15 (assay ID HS01921425_s1), ISG54 (assay ID Hs0192
2738_s1), or GAPDH (4333764F) on a 7500 Fast Real time PCR system (Applied Biosystems).
Relative mRNA levels were determined using the ΔΔCt method, normalized to GAPDH, and
expressed relative to indicated treatments. Data presented is from a minimum of two indepen-
dent biological replicates, each analysed in triplicate (RQ/RQmin/max). Means (RQ) and stan-
dard deviations (RQmin/max) are presented. For input viral genome quantitation, vDNA was
extracted from infected HFt cells harvested at 90 mpi. Cells were trypsinised, pelleted by cen-
trifugation (500 xg, 10 min), washed twice in PBS, and resuspended in PBS containing 1% SDS
and 300mM Sodium acetate (pH 5.2). Total DNA was isolated by phenol chloroform extrac-
tion and ethanol precipitation, and resuspended in Tris buffer (10mM Tris-HCl pH 8.5).
qPCR was performed using two virus specific (UL30 and UL36) primer-probe sets with dis-
tinct fluorophores (Sigma-Aldrich; S3 Table) in duplex reactions performed in triplicate per
biological replicate. Quantitation was performed against standards of known concentration
derived from a purified infectious HSV-1 17syn+ BAC clone (SR27 DNA, [95]; a kind gift
from Andrew Davison MRC-UoG CVR).
Supporting information
S1 Fig. HSV-1 replication is sensitive to EdU or EdC labelling in a cell type and ICP0-de-
pendent manner. (A, D, G) RPE or HEL cells (as indicated) were infected with 100 PFU of
either WT or ΔICP0 HSV-1 and incubated in the presence of DMSO, ACG (50 μM), EdU or
EdC (0.5–10 μM, as indicated) for 24 h. Plaque counts were determined and expressed relative
to DMSO control (1) and presented as relative PFE. n 3, means and standard deviations
shown. (B, E, H) RPE or HEL cells (as indicated) were infected (as in A) and plaque diameters
measured at 24 hpi. Boxes: 25th to 75th percentile range; black line: median plaque size; whis-
kers: 5th to 95th percentile range. n 100 plaque measurements from 4 independent infections.
(C, F, I) RPE or HEL cells (as indicated) were infected with either WT (MOI 0.001 PFU/cell)
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or ΔICP0 (MOI 2 PFU/cell) HSV-1 in the presence of EdU or dU at the indicate concentra-
tions. CRV was collected at 48 hpi and titres determined on U2OS cells. n 3, means and
standard deviations are shown.
(EPS)
S2 Fig. Detection of viral genomes within HSV-1EdC virions requires permeabilization of
the capsid by GuHCl treatment. 1x108 PFU of HSV-1EdC virions were incubated in TNE
buffer or TNE buffer containing 2M GuHCl at 4˚C for 60 mins, as described in [47]. EdC
labelled vDNA (red) and capsids (green) were detected by click chemistry and indirect immu-
nofluorescence staining for VP5 (the major capsid protein), respectively.
(EPS)
S3 Fig. PML-NB proteins entrap vDNA upon nuclear entry. Individual channel images
for data presented in Fig 3. Localization of PML (green) with HSV-1EdU vDNA (red, white
arrows), and PML-NB constituent proteins (Daxx, Sp100, ATRX, SUMO2/3) or IFI16 (cyan,
as indicated) at 90 mpi (post-addition of virus; MOI of 3 PFU/cell) or equivalent mock infected
cells (as indicated). Insets show magnified regions of interest (dashed boxes) highlighting host
protein localization with vDNA. Cut mask (yellow) highlights regions of colocalization
between host proteins and vDNA (as indicated). Weighted colocalization coefficients are
shown.
(EPS)
S4 Fig. PML-NBs entrap HSV-1 vDNA in an ICP0-independent manner. Confocal micros-
copy images as for data presented in Fig 3 for ΔICP0EdU infection. Localization of PML
(green) with infecting ΔICP0EdU vDNA (red, white arrows) and PML-NB constituent proteins
(Daxx, Sp100, ATRX, SUMO2/3) or IFI16 (cyan, as indicated) at 90 mpi (post-addition of
virus; MOI of 3 PFU/cell). Insets show magnified regions of interest (dashed boxes) highlight-
ing host protein localization with vDNA. Cut mask (yellow) highlights regions of colocaliza-
tion between host proteins and vDNA (as indicated). Weighted colocalization coefficients are
shown.
(EPS)
S5 Fig. IFI16 and PML colocalization with vDNA over a range of MOI. (A,B) HFt cells were
infected with HSV-1EdU over a range of MOIs (1–50 PFU/cell, as indicated). Cells were fixed
and permeabilized at 90 mpi (post-addition of virus). vDNA, IFI16 and PML, were detected by
click chemistry and indirect immunofluorescence staining, respectively. (A) Confocal micros-
copy images showing IFI16 (green) dots at the nuclear rim in association with PML (cyan) and
vDNA (red) at an MOI of 50. White arrow highlights vDNA colocalization with IFI16 and
PML. Yellow arrow highlights vDNA colocalization with PML only. Correspondingly coloured
insets show magnified regions of interest (dashed boxes). Cut mask (yellow) highlights regions
of colocalization between IFI16, PML, and vDNA (as indicated). Weighted (w.) colocalization
coefficients shown. (B) Scatter plot showing paired w. colocalization coefficients of IFI16 and
PML to individual nuclear infecting viral genomes (as described above). n 250 genomes
per sample population derived from a minimum of two independent infections. (C) Quantita-
tion of host protein recruitment to infecting viral genomes (as in B). Boxes: 25th to 75th percen-
tile range; black line: median weighted (w.) colocalization coefficient; whiskers: 5th to 95th
percentile range. Solid line indicates coincident threshold level (weighted colocalization
coefficients < 0.2). (D) HFt cells were HSV-1EdU infected at an MOI 10 PFU/cell. Cells were
fixed and permeabilized at either 15 or 30 mpi (post-addition of virus). Scatter plot showing
paired w. colocalization coefficients of IFI16 and PML to individual nuclear infecting viral
genomes. n 60 genomes per sample population derived from a minimum of two
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independent infections. (E) Quantitation of host protein recruitment to infecting viral
genomes (as shown in D). Boxes: 25th to 75th percentile range; black line: median weighted
(w.) colocalization coefficient; whiskers: 5th to 95th percentile range. Solid line indicates coinci-
dent threshold level (weighted colocalization coefficients < 0.2).  P< 0.01,  P< 0.001, ns
(not significant); Mann-Whitney U-test.
(EPS)
S6 Fig. Depletion of PML does not enhance IFI16 recruitment to ΔICP0EdU infecting viral
genomes. Individual channel images for data presented in Fig 4 for ΔICP0EdU infection. Local-
ization of PML (green), and either Daxx or IFI16 (cyan; as indicated) to infecting ΔICP0EdU
vDNA (red, white arrows) in HFt shCtrl and shPML cells at 90 mpi (post-addition of virus;
MOI of 3 PFU/cell). Insets show magnified regions of interest (dashed boxes) highlighting
host protein localization with vDNA. Cut mask (yellow) highlights regions of colocalization
between PML, IFI16, Daxx, and vDNA (as indicated). Weighted colocalization coefficients are
shown.
(EPS)
S7 Fig. Recruitment of IFI16 and eYFP.ICP4 to ΔICP0EdU vDNA in an asynchronous pla-
que-edge recruitment assay. HFt cells were infected with ΔICP0.eYFP.ICP4 at an MOI of 2
PFU/cell for 24h prior to pulse labelling with EdU for 6h. Representative images show the cel-
lular localization of eYFP.ICP4 (green), vDNA (red), and IFI16 (cyan) in cells associated with
a developing ΔICP0.eYFP.ICP4 plaque. (Left) Wide-field view of the plaque-body with newly
infected cells on the periphery of the plaque-edge highlighted (dashed boxes; regions of inter-
est 1–3). (Right) Single cell images of regions of interest (dashed boxes 1–3, respectively) show-
ing nuclei at different stages of infection. Box 1: Infected nucleus with robust vDNA
replication compartments. Box 2: Asymmetrically infected nucleus with early stage vDNA rep-
lication compartments. Box 3: Asymmetrically distributed EdU labelled nuclear infecting viral
genomes that have yet to initiate viral IE (eYFP.ICP4) gene expression. IFI16 is only detected
in association with vDNA that has initiated IE gene expression.
(EPS)
S8 Fig. PML-NB entrapment of vDNA occurs in a cell type dependent manner. Individual
channel images from data presented in Fig 10. Localization of PML (green) and Daxx (cyan)
with vDNA (red, white arrows) in HSV-1EdU infected HFt, RPE, U2OS, or SAOS cells at 30
mpi (post-addition of virus; MOI 3 PFU/cell). Insets show magnified regions of interest
(dashed boxes) highlighting PML and Daxx localization with vDNA. Cut mask (yellow) high-
lights regions of colocalization between PML or Daxx and vDNA (as indicated). Weighted
colocalization coefficients are shown.
(EPS)
S1 Table. EdU or EdC treatment of infected cell monolayers inhibits wild-type (strain
17syn+) and ICP0-null mutant (dl1403/ΔICP0) HSV-1 plaque formation efficiency (PFE)
in a cell-type and dose-dependent manner. Plaque counts expressed relative to DMSO con-
trol monolayers, (# of plaques treated / # of plaques DMSO control) at equivalent serial dilu-
tions of virus and presented as relative plaque formation efficiency (PFE). n 3, means and
standard deviations (in brackets) shown. Small plaque phenotypes at 24–36 hpi highlighted.
(DOCX)
S2 Table. Particle to PFU and genome to PFU ratios of EdU labelled wild-type and ICP0--
null mutant (dl1403/ΔICP0) HSV-1 stock preparations in permissive (U2OS) and restric-
tive (HFt) cell types. Mean particles/ml determined from a minimum of 6 independent fields
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of view. Mean PFU/ml determined from 3 independent titrations on either U2OS or HFt (as
indicated). Mean genome copy number/U2OS PFU determined from triplicate qPCR reac-
tions from 2 independent experiments. PS, plate stock (no ultracentrifugation).
(DOCX)
S3 Table. Primer-probe sets used for HSV-1 vDNA quantitation by qPCR.
(DOCX)
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